Updated July 2019

NICE has accredited the process used by the National Osteoporosis Guideline Group to produce Clinical guideline for the prevention and treatment of osteoporosis. Accreditation is valid for 5 years from 7 March 2017.

Aims of NOGG

The National Osteoporosis Guideline Group (NOGG) comprises a multidisciplinary group including patient representation and professionals involved in the care of people with osteoporosis. It was established in 2007 to provide a clinical guideline for the management of men and women at high fracture risk, using the output from the FRAX calculator. Specifically, it aims to:
  • Provide assessment thresholds for the use of BMD i.e. the fracture probabilities at which a BMD test might or might not be recommended.
  • Provide intervention thresholds i.e. fracture probabilities at which treatment is recommended.
This updated NOGG Guideline has been produced with the support of the Bone Research Society, British Geriatric Society, British Orthopaedic Association, British Orthopaedic Research Society, International Osteoporosis Foundation, Primary Care Rheumatology Society, Royal Pharmaceutical Society, Society of Endocrinology, National Osteoporosis Society, Osteoporosis 2000 and Osteoporosis Dorset. The Guideline has also been endorsed by the Royal College of General Practitioners.

Clinical use of FRAX® and NOGG Guideline

The guideline is based on an opportunistic case finding strategy in which physicians and other healthcare professionals are alerted to the possibility of high fracture risk by the presence of clinical risk factors (CRFs) associated with fracture
Management algorithm for the assessment of patients at risk of fracture:
Management algorithm for the assessment of patients at risk of fracture

Centre for Metabolic Bone Diseases, University of Sheffield, UK